Financials Jan 21, 2022 10:39 AM (GMT+8) · EqualOcean
Shenzhen silicon-based Bionic Technology Co., Ltd. has recently completed a C + + round of financing of more than 500 million yuan, which is jointly led by CPE Yuanfeng and Guoshou science and Innovation Fund under Guoshou investment company, followed by former sea master fund, concurrent fixed capital, construction and development emerging investment, Jingming capital and old shareholder Luxin venture capital. This round of financing will be used for technology upgrading, market promotion and new product line development of CGM products. It is understood that the current key business of silicon-based bionics GS1 silicon-based dynamic continuous glucose monitoring system (CGM) has been approved by the State Drug Administration on November 4, 2021.